Evidence map›Paper›PMID 32680446›Full record

ArticleTissue engineering. Part A2021

The Survey on Cellular and Tissue-Engineered Therapies in Europe in 2016 and 2017.

Max H P Gay, Helen Baldomero, Dominique Farge-Bancel, Pamela G Robey, Scott Rodeo, Jakob Passweg, Magdalena Müller-Gerbl, Ivan Martin

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tissue engineering. Part A, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. The Landscape of Advanced Therapy Medicinal Products in Slovenian Transfusion Medicine: A Review of Past and Future Outlook.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2026
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Max H P GayDepartment of Biomedicine, Institute of Anatomy, University Hospital Basel, University of Basel, Basel, Switzerland.
Helen BaldomeroEBMT Activity Survey Office, Division of Hematology, University Hospital Basel, University of Basel, Basel, Switzerland.
Dominique Farge-BancelUnité de Médecine Interne, Maladies Auto-immunes et Pathologie Vasculaire, Université de Paris, Paris, France.
Pamela G RobeyNational Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.
Scott RodeoOrthopaedic Surgery, Weill Medical College of Cornell University, New York, New York, USA.
Jakob PasswegEBMT Activity Survey Office, Division of Hematology, University Hospital Basel, University of Basel, Basel, Switzerland.
Magdalena Müller-GerblDepartment of Biomedicine, Institute of Anatomy, University Hospital Basel, University of Basel, Basel, Switzerland.
Ivan MartinDepartment of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
University Hospital of Basel · CHHospital for Special Surgery · USUniversity of Basel · CH

Funding

The role of stem cells in skeletal health and diseaseZIADE000380 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI ROBEY, PAMELA G · 2009 to 2025
$30.6M
6 · The paper itself

Abstract

This report describes activity in Europe for the years 2016 and 2017 in the area of cellular and tissue-engineered therapies, excluding hematopoietic stem cell treatments for the reconstitution of hematopoiesis. It is the eighth of its kind and is supported by five established scientific organizations. In 2016 and 2017, a combined 234 teams from 29 countries responded to the cellular and engineered tissue therapy survey; 227 teams reported treating 8236 patients in these 2 years. Indications were categorized in

Indexed as

Mesenchymal Stem CellsMesenchymal Stem Cell TransplantationCell- and Tissue-Based TherapyEuropeHumansTissue Engineeringcellular therapyclinical trialregenerative medicinetissue engineering

Identifiers

PMID32680446
PMCPMC8035930
OpenAlexW3042229635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.